Hyun-jung Park
Waegwan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Functional Characterization of Breast Milk-Derived Lactobacillus paragasseri HUH02 Postbiotic Preparations with Immunomodulatory, Skin Barrier-Protective, and Anti-Melanogenic Activities.
Journal: Microorganisms
Published: June 29, 2026
Characterization of Goat Meat Quality Under Different Forage Feeding Regimes.
Journal: Animals : an open access journal from MDPI
Published: June 11, 2026
Hexaconazole-Induced Male Reproductive Toxicity Through ROS-Mediated Ferroptosis and Impaired Leydig Cell Steroidogenesis.
Journal: International journal of molecular sciences
Published: May 22, 2026
7-Ketocholesterol plays a key role in cholesterol-induced hepatitis via macrophage and neutrophil infiltration.
Journal: The Journal of nutritional biochemistry
Published: July 23, 2023
High Cholesterol-Induced Bone Loss Is Attenuated by Arctiin via an Action in Osteoclasts.
Journal: Nutrients
Published: September 12, 2022
Doxorubicin Induces Bone Loss by Increasing Autophagy through a Mitochondrial ROS/TRPML1/TFEB Axis in Osteoclasts.
Journal: Antioxidants (Basel, Switzerland)
Published: June 14, 2022
Morin Disrupts Cytoskeleton Reorganization in Osteoclasts through an ROS/SHP1/c-Src Axis and Grants Protection from LPS-Induced Bone Loss.
Journal: Antioxidants (Basel, Switzerland)
Published: April 05, 2022
Estrogen Decreases Cytoskeletal Organization by Forming an ERα/SHP2/c-Src Complex in Osteoclasts to Protect against Ovariectomy-Induced Bone Loss in Mice.
Journal: Antioxidants (Basel, Switzerland)
Published: February 23, 2021
Dauricine Protects from LPS-Induced Bone Loss via the ROS/PP2A/NF-κB Axis in Osteoclasts.
Journal: Antioxidants (Basel, Switzerland)
Published: May 16, 2020
Lycorine Attenuates Autophagy in Osteoclasts via an Axis of mROS/TRPML1/TFEB to Reduce LPS-Induced Bone Loss.
Journal: Oxidative medicine and cellular longevity
Published: June 19, 2019
MicroRNA-29b Enhances Osteoclast Survival by Targeting BCL-2-Modifying Factor after Lipopolysaccharide Stimulation.
Journal: Oxidative medicine and cellular longevity
Published: November 07, 2018
4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts.
Journal: Biochemical pharmacology
Published: December 28, 2017
Last Updated: 09/26/2026